PNC Financial Services Group
TRIB

PNC Financial Services Group’s Trinity Biotech TRIB Stock Holding History

PNC Financial Services Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-25
Closed -$1K – 4211
2016
Q4 		$1K Hold
25
– – ﹤0.01% 3937
2016
Q3 		$2K Sell
25
-4,000
-99% -$249K ﹤0.01% 3833
2016
Q2 		$227K Hold
4,025
– – ﹤0.01% 2000
2016
Q1 		$235K Hold
4,025
– – ﹤0.01% 2005
2015
Q4 		$237K Sell
4,025
-400
-9% -$23.6K ﹤0.01% 1974
2015
Q3 		$252K Buy
4,425
+400
+10% +$32.2K ﹤0.01% 1983
2015
Q2 		$364K Hold
4,025
– – ﹤0.01% 1836
2015
Q1 		$388K Buy
4,025
+25
+0.6% +$2.31K ﹤0.01% 1798
2014
Q4 		$350K Hold
4,000
– – ﹤0.01% 1743
2014
Q3 		$366K Sell
4,000
-3,337
-45% -$361K ﹤0.01% 1651
2014
Q2 		$844K Buy
7,337
+9
+0.1% +$1.07K ﹤0.01% 1155
2014
Q1 		$887K Buy
7,328
+3,328
+83% +$436K ﹤0.01% 1119
2013
Q4 		$502K Hold
4,000
– – ﹤0.01% 1378
2013
Q3 		$436K Buy
+4,000
New +$390K ﹤0.01% 1430

Other funds holding TRIB

PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $756M AUM 19.99% 1-Year Est. Return

PNC Financial Services Group's TRIB Position: Q1 2017 in Review

PNC Financial Services Group sold out of Trinity Biotech (TRIB) in Q1 2017, closing a stake of 25 shares — an estimated $1K sold.

PNC Financial Services Group first reported a position in TRIB in Q3 2013 and held it in 14 quarters. The position peaked at $887K in Q1 2014. 67 funds tracked by Wall St. Rank hold TRIB as of Q1 2017.

  • PNC Financial Services Group reported no remaining Trinity Biotech position as of Q1 2017 after selling out during the quarter.
  • PNC Financial Services Group sold 25 Trinity Biotech shares in Q1 2017, an estimated $1K.
  • PNC Financial Services Group first reported a position in Trinity Biotech in Q3 2013 and held it in 14 quarters.
  • PNC Financial Services Group's Trinity Biotech position peaked at $887K in Q1 2014.
  • 67 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2017.

Based on PNC Financial Services Group's 13F filing for Q1 2017, filed 12 May 2017.